FOR IMMEDIATE RELEASE
Myocardial Solutions Brings Advanced Cardiac Imaging to Medical Cener at Ocean Reef
Key Largo, FL – 5/19/2025 – Myocardial Solutions recently provided its cutting-edge cardiac diagnostic technology, MyoStrain, to the medical team at The Medical Center at Ocean Reef. Members of the Ocean Reef community received access to this non-invasive imaging solution, designed to detect early signs of heart dysfunction well before symptoms appear.
Through this event, Ocean Reef clinicians provided access to their members and patients, delivering a fast, accurate heart health assessment that can lead to early detection of heart issues.
MyoStrain is a breakthrough cardiac MRI technology that measures heart muscle function in 10 minutes without the need for contrast agents, stress agents, or ionizing radiation. It enables physicians to detect myocardial dysfunction earlier than traditional imaging methods, supporting proactive care and improved patient outcomes.
“We are excited about being able to bring the innovative technology of MyoStrain to our members at Ocean Reef,” said Keith Young, Chief Executive Officer. “This technology provides our community with access to a new level of cardiac care. Our physicians and staff are equally enthusiastic, as they see how MyoStrain has the ability to enhance early detection and improve outcomes for our patients.”
Bruce Trittin, Senior Vice President of Sales for Myocardial Solutions, emphasized the importance of this outreach: "Providing access to MyoStrain at Ocean Reef was a tremendous opportunity to introduce this powerful technology to a health-conscious community. The feedback was incredibly positive, and we’re thrilled to see growing interest in early cardiac diagnostics."
This event reflects Myocardial Solutions' mission to expand access to cutting-edge heart health technology across communities through mobile and in-clinic partnerships.
For more information about The Medical Center at Ocean Reef, visit: https://www.mcor.org
To learn more about Myocardial Solutions and MyoStrain, visit: https://www.myocardialsolutions.com
About Myocardial Solutions, Inc.
Myocardial Solutions, Inc. (MSI) is a medical technology company focused on transforming cardiac diagnostics through advanced magnetic resonance imaging. Its flagship product, MyoStrain, allows physicians to detect early myocardial dysfunction in under 10 minutes, with no contrast or stress agents. By enabling early diagnosis and monitoring, MyoStrain empowers clinicians to deliver more personalized, preventative cardiac care. MSI is committed to innovation that improves outcomes and enhances quality of life for patients around the world.
PR@myocardialsolutions.com
919.677.8100
Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, MRI-based heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.
To learn more about MyoStrain, visit myocardialsolutions.com or connect with us on LinkedIn and Twitter @myocardialsoln.
808 Aviation Pkwy, Suite 700 | Morrisville, NC 27560 | myocardialsolutions.com | ph: +1.919.677.8100
© Copyright 2022 Myocardial Solutions Inc. All rights reserved. MyoStrain® and the MyoHealthTM
Score are among the trademarks of Myocardial Solutions.